Surviving and Thriving with ADHD: Part 2- Pharmacist
Attention-deficit/hyperactivity disorder (ADHD) is one of
the most common neurodevelopmental disorders of childhood,
affecting as many as 5-10% of children and adolescents and 2.5-
5% of adults. It is a serious public health concern because of its
high prevalence, long-term course, and functional impairment
at home, school and work. ADHD can be effectively managed
with a variety of treatment options, including parent training,
school interventions, medications, and behavioral strategies.
Currently, there is debate about the overdiagnosis of ADHD leading
to inappropriate treatment and stigmatization, or missed diagnoses
of conditions with similar symptoms as ADHD (eg, anxiety,
speech or language delay, developmental disorder).
This issue is the second of a 2-part review of ADHD. Part
1 focuses on current stimulant and nonstimulant treatments for
ADHD. Part 2 summarizes the pathophysiology and clinical
presentation of ADHD across all age groups, recommended nondrug
and behavioral interventions for managing ADHD, clinically
significant drug interactions with ADHD medications, and coexisting
conditions that are often present in patients with ADHD.